{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:34:05Z","timestamp":1779183245761,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cmi.2018.03.039","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T12:33:32Z","timestamp":1523277212000},"page":"108.e9-108.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Adjuvant non-bacteriolytic and anti-inflammatory combination therapy in pneumococcal meningitis: an investigation in a mouse model"],"prefix":"10.1016","volume":"25","author":[{"given":"M.","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"H\u00f6hne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Angele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"H\u00f6gen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.W.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"T\u00fcfekci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Koedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.03.039_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in The Netherlands, 2006\u201314: a prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2018.03.039_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13054-016-1498-8","article-title":"Dramatic reduction of mortality in pneumococcal meningitis","volume":"20","author":"Buchholz","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2018.03.039_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/awh711","article-title":"Neuropsychological sequelae of bacterial and viral meningitis","volume":"129","author":"Schmidt","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.cmi.2018.03.039_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1741-7015-7-47","article-title":"Sequelae due to bacterial meningitis among african children: a systematic literature review","volume":"7","author":"Ramakrishnan","year":"2009","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2018.03.039_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/QCO.0b013e328337f49e","article-title":"New understandings on the pathophysiology of bacterial meningitis","volume":"23","author":"Koedel","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2018.03.039_bib6","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1038\/nrdp.2016.74","article-title":"Community-acquired bacterial meningitis","volume":"2","author":"van de Beek","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cmi.2018.03.039_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1586\/eri.11.129","article-title":"Bacterial meningitis: current therapy and possible future treatment options","volume":"9","author":"Woehrl","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2018.03.039_bib8","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/AAC.00674-12","article-title":"Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis","volume":"56","author":"Grandgirard","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.03.039_bib9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1128\/AAC.00812-09","article-title":"Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis","volume":"54","author":"Grandgirard","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.03.039_bib10","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/AAC.01014-06","article-title":"Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis","volume":"51","author":"Grandgirard","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.03.039_bib11","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","article-title":"Dexamethasone in adults with bacterial meningitis","volume":"347","author":"de Gans","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2018.03.039_bib12","article-title":"Corticosteroids for acute bacterial meningitis","volume":"9","author":"Brouwer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2018.03.039_bib13","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4049\/jimmunol.178.3.1861","article-title":"Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system","volume":"178","author":"Rupprecht","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2018.03.039_bib14","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1172\/JCI57522","article-title":"Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis","volume":"121","author":"Woehrl","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cmi.2018.03.039_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12974-015-0372-y","article-title":"Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: a randomized controlled trial","volume":"12","author":"Kasanmoentalib","year":"2015","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.cmi.2018.03.039_bib16","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.4049\/jimmunol.170.9.4724","article-title":"Il-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis","volume":"170","author":"Zwijnenburg","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2018.03.039_bib17","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.4049\/jimmunol.1100790","article-title":"The nlrp3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsie b release","volume":"187","author":"Hoegen","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2018.03.039_bib18","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nm1468","article-title":"Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis","volume":"12","author":"Rossi","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2018.03.039_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000461","article-title":"Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis","volume":"5","author":"Koedel","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2018.03.039_bib20","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/brain\/awt064","article-title":"High mobility group box 1 prolongs inflammation and worsens disease in pneumococcal meningitis","volume":"136","author":"Hohne","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.cmi.2018.03.039_bib21","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1128\/AAC.00148-13","article-title":"Adjunctive N-acetyl-L-cysteine in treatment of murine pneumococcal meningitis","volume":"57","author":"Hogen","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.03.039_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-8-7","article-title":"Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis","volume":"8","author":"Demel","year":"2011","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.cmi.2018.03.039_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000109868","article-title":"Daptomycin: a review 4 years after first approval","volume":"81","author":"Sauermann","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.cmi.2018.03.039_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cbpa.2009.02.031","article-title":"Daptomycin: mechanisms of action and resistance, and biosynthetic engineering","volume":"13","author":"Baltz","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.cmi.2018.03.039_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2202-14-42","article-title":"Attenuation of cognitive impairment by the nonbacteriolytic antibiotic daptomycin in Wistar rats submitted to pneumococcal meningitis","volume":"14","author":"Barichello","year":"2013","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.cmi.2018.03.039_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jmii.2015.07.014","article-title":"Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules","volume":"50","author":"Vivas","year":"2015","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2018.03.039_bib27","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1128\/AAC.00952-08","article-title":"The combination of daptomycin plus ceftriaxone was more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone","volume":"53","author":"Egermann","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.03.039_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-3639.2003.tb00012.x","article-title":"Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis","volume":"13","author":"Klein","year":"2003","journal-title":"Brain Pathol"},{"key":"10.1016\/j.cmi.2018.03.039_bib29","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/AAC.01741-10","article-title":"Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections","volume":"55","author":"Kullar","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.03.039_bib30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jac\/dkl007","article-title":"Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis","volume":"57","author":"Gerber","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.03.039_bib31","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/AAC.48.10.3928-3933.2004","article-title":"Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis","volume":"48","author":"Cottagnoud","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2018.03.039_bib32","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1345\/aph.1P307","article-title":"Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis","volume":"44","author":"Riser","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cmi.2018.03.039_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.diagmicrobio.2013.01.021","article-title":"Daptomycin plus trimethoprim\/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis","volume":"76","author":"Vena","year":"2013","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18303173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18303173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:20:22Z","timestamp":1761117622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18303173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1198743X18303173"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.03.039","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant non-bacteriolytic and anti-inflammatory combination therapy in pneumococcal meningitis: an investigation in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}